Search by Drug Name or NDC
NDC 35573-0458-85 NICARDIPINE HYDROCHLORIDE 30 mg/1 Details
NICARDIPINE HYDROCHLORIDE 30 mg/1
NICARDIPINE HYDROCHLORIDE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Burel Pharmaceuticals, LLC. The primary component is NICARDIPINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Nicardipine is used to treat high blood pressure and to control angina (chest pain). Nicardipine is in a class of medications called calcium channel blockers. It lowers blood pressure by relaxing the blood vessels so the heart does not have to pump as hard. It controls chest pain by increasing the supply of blood and oxygen to the heart. High blood pressure is a common condition and when not treated, it can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 35573-0458-85Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Nicardipine
Product Information
| NDC | 35573-0458 |
|---|---|
| Product ID | 35573-458_f47b85b1-a7d3-437b-a3db-a81e1f1716c4 |
| Associated GPIs | |
| GCN Sequence Number | 000578 |
| GCN Sequence Number Description | nicardipine HCl CAPSULE 30 MG ORAL |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 02391 |
| HICL Sequence Number | 000183 |
| HICL Sequence Number Description | NICARDIPINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | NICARDIPINE HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nicardipine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | NICARDIPINE HYDROCHLORIDE |
| Labeler Name | Burel Pharmaceuticals, LLC |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA215377 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 35573-0458-85 (35573045885)
| NDC Package Code | 35573-458-85 |
|---|---|
| Billing NDC | 35573045885 |
| Package | 90 CAPSULE in 1 BOTTLE (35573-458-85) |
| Marketing Start Date | 2023-01-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |